Clinical trial
Extracellular Fluid in Resistant Hypertension
NCT00141596 · St George's, University of London, Other · Terminated
Key facts
| NCT number | NCT00141596 |
|---|---|
| Title | Extracellular Fluid in Resistant Hypertension |
| Official title | A Study to Investigate the Contribution of Extracellular Fluid Volume Expansion to Drug Resistant Hypertension |
| Lead sponsor | St George's, University of London, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Cardura XL 4 mg bd, Amiloride 5 mg bd, Furosemide 40 mg bd |
| Enrollment | 32 |
| Start date | Jul 1, 2003 |
| Completion | Oct 1, 2006 |
| First posted | Sep 1, 2005 |
| Last update posted | Jun 9, 2015 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: